de Camargo Júlia Drummond, de Souza Fernanda Avallone Machado Laureano, de Carvalho Ramalho de Oliveira Ivy, Barbosa Jéssica Anastacia Silva
Nurse, Palliative Care Service, Hospital Samaritano.
Physiotherapist, Oncology Department, Hospital Sírio Libanês.
Can Oncol Nurs J. 2023 Nov 1;33(4):436-443. doi: 10.5737/23688076334436. eCollection 2023 Fall.
Glioblastoma Multiforme is a deadly brain cancer that is very challenging for patients and their families. It is associated with rapid progression, cognitive decline, and a low survival rate.
To determine whether deceased Glioblastoma Multiforme patients had received follow-up service from the palliative care team before their death, whether invasive measures had been reduced, and whether the last antineoplastic treatment was given within 14-30 days before death.
A retrospective study utilizing chart data from January 2020 to March 2022 from an institutional project. Data were gathered to reflect selected indicators of quality of care for palliative care patients.
Of the 30 hospitalized patients with Glioblastoma Multiforme who had died while in hospital, 50% had received support from the palliative care team. Two patients (6.7%) had undergone antineoplastic treatment in the last 14 days of life and 13 (43.3%) had an order limiting invasive measures defined in the last two weeks of life.
In half of the patients monitored by a palliative care team, antineoplastic treatment and limitation of invasive measures occurred in the last 14 days of life. This may be associated with increased suffering of patients, family members, and professionals. Discussions about end-of-life care-related choices and goals of care need to be respected.
多形性胶质母细胞瘤是一种致命的脑癌，对患者及其家属来说极具挑战性。它与疾病快速进展、认知能力下降和低生存率相关。
确定已故的多形性胶质母细胞瘤患者在死亡前是否接受了姑息治疗团队的随访服务，侵入性措施是否减少，以及最后一次抗肿瘤治疗是否在死亡前14至30天内进行。
一项回顾性研究，利用了2020年1月至2022年3月一个机构项目的病历数据。收集数据以反映姑息治疗患者护理质量的选定指标。
在30名住院期间死亡的多形性胶质母细胞瘤患者中，50% 接受了姑息治疗团队的支持。两名患者（6.7%）在生命的最后14天接受了抗肿瘤治疗，13名患者（43.3%）在生命的最后两周有一项限制侵入性措施的医嘱。
在接受姑息治疗团队监测的患者中，有一半在生命的最后14天接受了抗肿瘤治疗并限制了侵入性措施。这可能会增加患者、家属和专业人员的痛苦。需要尊重关于临终护理相关选择和护理目标的讨论。
